Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Return on Invested Capital (2016 - 2025)

Biomerica's Return on Invested Capital history spans 12 years, with the latest figure at 0.19% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 14.0% year-over-year to 0.19%; the TTM value through Nov 2025 reached 0.19%, down 14.0%, while the annual FY2025 figure was 0.2%, 6.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.19% at Biomerica, down from 0.22% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.47% in Q1 2025 and bottomed at 1.08% in Q1 2023.
  • The 5-year median for Return on Invested Capital is 0.59% (2021), against an average of 0.39%.
  • The largest annual shift saw Return on Invested Capital crashed -60bps in 2023 before it skyrocketed 124bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.74% in 2021, then grew by 4bps to 0.72% in 2022, then grew by 13bps to 0.63% in 2023, then soared by 153bps to 0.33% in 2024, then plummeted by -42bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Return on Invested Capital are 0.19% (Q4 2025), 0.22% (Q2 2025), and 0.47% (Q1 2025).